03/07/2023 Biopharma Dive: GPCR-targeting drugs: A renewed focus on a ubiquitous group of proteins Read More
03/16/2022 Fierce Biotech: Septerna emerges with $100M to spark ‘second golden age’ of prolific drug target GPCR with pioneer as co-founder Read More
03/16/2022 ENDPOINTS: A new Third Rock startup seeks a ‘second golden age’ of GPCR drug discovery based on Nobel laureate’s work Read More